-
Episode 65- Tariq Ghayur on the Renaissance of Bispecifics and ADCs, AI, and More
- 2024/09/10
- 再生時間: 32 分
- ポッドキャスト
-
サマリー
あらすじ・解説
September 10, 2024 | In this episode of The Chain, host Nimish Gera speaks with Tariq Ghayur, founder of FairJourney Biologics (and a fellow host of the podcast), about the current renaissance of bispecifics and ADCs, the impact of AI in pharmaceuticals, and what to watch out for in the biopharma space in the next few years. Ghayur also shares his journey from BASF Pharma to AbbVie, what it was like when the industry shifted its focus from small molecules to biologics, and the major differences between doing a postdoc in academia versus in the industry.